Calcium-transporting ATPases, or plasma membrane calcium ATPases (PMCA), are crucial components of cellular signaling that maintain calcium ion gradients across the plasma membrane. These ATPases play a pivotal role in regulating intracellular calcium levels, which in turn influence numerous cellular processes such as muscle contraction, neurotransmission, gene expression, and cell proliferation. PMCA enzymes actively transport calcium ions out of the cell, counteracting the influx of calcium ions from extracellular sources or intracellular stores like the endoplasmic reticulum. By tightly controlling calcium concentrations, PMCA ATPases contribute to the precise spatial and temporal regulation of calcium-mediated signaling cascades. These enzymes are particularly important in neurons, where proper calcium balance is crucial for synaptic transmission and plasticity.
The significance of PMCA inhibitors lies in their ability to modulate cellular calcium signaling and impact various physiological and pathological processes. Small molecules like Caloxin 1C1 specifically target PMCA isoforms, interfering with their activity and thereby altering calcium transport. Such inhibitors offer valuable tools for research into the roles of PMCA isoforms in different cellular contexts.
VEJA TAMBÉM
Nome do Produto | CAS # | Numero de Catalogo | Quantidade | Preco | Uso e aplicacao | NOTAS |
---|---|---|---|---|---|---|
Carbonyl Cyanide m-Chlorophenylhydrazone | 555-60-2 | sc-202984A sc-202984 sc-202984B | 100 mg 250 mg 500 mg | $75.00 $150.00 $235.00 | 8 | |
Inibe indiretamente o PMCA4 (codificado por ATP2B2), perturbando a função mitocondrial e diminuindo os níveis de ATP. | ||||||
Aurintricarboxylic Acid | 4431-00-9 | sc-3525 sc-3525A sc-3525B sc-3525C | 100 mg 1 g 5 g 10 g | $20.00 $31.00 $47.00 $92.00 | 13 | |
Foi relatado que a ATA inibe o PMCA1, entre outros alvos celulares, afectando a dinâmica do cálcio celular. | ||||||
Calmidazolium chloride | 57265-65-3 | sc-201494 sc-201494A | 10 mg 50 mg | $153.00 $600.00 | 27 | |
O calmidazólio é conhecido por inibir a PMCA1 e outras proteínas reguladoras do cálcio, afectando as vias de sinalização do cálcio. |